RiboClub Opening Session
The RiboClub Annual Meeting serves as the opening session of year long activities and seminars by students and trainees at all levels. The annual meeting encourages the exchange of ideas and stimulates collaborations between RNA biologists around the world. The meeting covers different topics related to the chemistry, structure and biology of RNA with emphasis on upcoming and debatable biological questions. Each year, the RiboClub focuses on a different research topic or a community of RNA researchers to highlight new advances in RNA research and innovation and promote collaboration between scientists from different disciplines and research institutes.
The Future of RNA Technology
Celebrating a RiboClub Milestone
September 30 – October 4, 2024
Ottawa Conference and Event Centre
Ottawa, Canada
Late Registration Deadline August 30
50% oral presentations selected from submitted abstracts
An event jointly organized by RiboClub, RiboWest, and The Toronto RNA Club/Enthusiasts’ Day (TREnD), the inaugural RNA Canada ARN 2024 conference will delve into the forefront of RNA technology and explore Canada’s pioneering leadership role in research and charting the course for the development of RNA-based innovations.
Topics:
RNA enzymes: A New Frontier of Biotechnology
Monitoring RNA in motion
RNA processing and maturation
Understanding RNA viruses
RNA: a new frontier for agriculture and forestry
Structure and function of regulatory RNA
AI & Computational Biology: Transforming massive seq data into function, targets and mechanism of action
RNA sensors, aptamers and bioengineering
New and untapped fields and application of RNA biology
Virus manipulation of host RNA cellular processes
RNA-based disease mechanisms of action
RNA modifications
Ribosomes: the ultimate drug targets
Regulation of RNA stability and decay
RNA binding proteins
Splicing and Disease
Translational Control
Plant RNA Biology
Ribonucleoprotein granules and spatial control of RNA regulation
Bacterial RNA and the new generation of antibiotics
Non-coding RNAs as markers and targets
Public Speakers:
Adrian Krainer, Cold Spring Harbor Laboratory, USA
Lynne Maquat, University of Rochester Medical Center, USA
Nahum Sonenberg, McGill University, Canada
Phillip Sharp, Massachusetts Institute of Technology, USA
Pieter Cullis, University of British Columbia, Canada
Tom Cech, University of Colorado Boulder, USA
Featured Speakers:
Alan Lambowitz, The University of Texas at Austin, USA
Anna Blakney, University of British Columbia, Canada
Anna Marie Pyle, Yale University, USA
Anne Simon, University of Maryland College Park, USA
Beatriz Fontoura, UT Southwestern, USA
Ben Blencowe, University of Toronto, Canada
Benoit Chabot, Université de Sherbrooke, Canada
Brenton Graveley, UConn Health,USA
Christine Vande Velde, Université de Montreal, Canada
Daniel Herschlag, Stanford University, USA
Daniel Zenklusen, Université de Montréal, Canada
David Bartel, Howard Hughes Medical Institute, USA
David Baulcombe, University of Cambridge, UK
Davide Ruggero, University of California San Francisco, USA
Eric Lai, Memorial Sloan Kettering Cancer Center, USA
Gene Yeo, UCSD, USA
Gisela Storz, NIH, USA
Hyongsok Tom Soh, Stanford University, USA
Jeannie Lee, Massachussetts General Hospital, Boston
Jeffrey Kieft, New York Structural Biology Center, USA
Jérôme Waldispuhl, McGill University, Canada
Jessica Tucker, The University of Iowa, USA
John Bell, Ottawa Hospital Research Institute
Joseph Puglisi, Stanford University, USA
Katharina Hofer, Max Planck Institute, Germany
Katherine Borden, Université de Montréal, Canada
Kristin Hope, University of Toronto, Canada
Lynne Maquat, University of Rochester, Rochester
Maria Barna, Stanford University, USA
Mark Belmonte, University of Manitoba, Canada
Marlene Oeffinger, Institut de recherches cliniques de Montréal, Canada
Martin Smith, Université de Montréal, Canada
Maureen McKeague, McGill University, Canada
Nebojsa Janjic, Somalogic, USA
Peter F. Johnson, NCI-Frederick, USA
Peter Sarnow, Stanford University, USA
Priya Banerjee, SUNY at Buffalo, USA
Rachel Green, Johns Hopkins University, USA
Raymund Wellinger, Université de Sherbrooke, Canada
Ronald Breaker, Yale University, USA
Sally Assmann, Pennsylvania State University, USA
Scott Blanchard, St. Jude’s Children’s Research Hospital, USA
Scott Kennedy, Harvard University, USA
Shuo Gu, National Cancer Institute, USA
Stephanie Moon, University of Michigan Medical School, USA
Steve Whyard, University of Manitoba, Canada
Sue Ackerman, Howard Hughes Medical Institute, USA
Tao Pan, University of Chicago, USA
Thomas Dever, NIH, USA
Ute Kothe, University of Manitoba, Canada
Victor Ambros, UMASS Medical School, USA
Wendy Gilbert, Yale School of Medicine, USA
Xiao Wang, Broad Institute of MIT and Harvard, USA
Xinnian Dong, Duke University, USA
Yong Wang, The Pennsylvania State University, USA
Session Chairs:
Artem Babaian, University of Toronto, Canada
Davoud Torkamaneh, Universite Laval, Canada
Éric Lécuyer, Institut de Recherches Cliniques de Montréal, Canada
Hong Han, McMaster University, Canada
Ly Vu, University of British Columbia, Canada
Maria Vera Ugalde, McGill University, Canada
Mark Bayfield, York University, Canada
Mark Belmonte, University of Manitoba, Canada
Markus Hafner, NIH, USA
Martin Simard, Université Laval, Canada
Neil Renwick, Queen’s University, Canada
Olena Zhulyn, SickKids & University of Toronto, Canada
Peter Unrau, Simon Fraser University, Canada
Ryan Hili, York University, Canada
Selena Sagan, UBC, Canada
William Faller, Netherlands Cancer Institute, NL
Yingfu Li, McMaster University, Canada
Yu Zhou, Wuhan University, China